Blog
Petri Dish: ProFound’s Novartis deal worth $750M, Dyne secures debt
In the past week, bluebird bio named new leaders after its acquisition, Dyne secured a debt deal and ProFound Therapeutics started working with Novartis.
In the past week, bluebird bio named new leaders after its acquisition, Dyne secured a debt deal and ProFound Therapeutics started working with Novartis.